Ionis Pharmaceuticals, Inc. ( IONS) - Key Metrics
IONS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.25 | -$1.41 | -$0.85 | -$0.98 |
| 2025Q3 | $0.97 | -$0.80 | -$0.82 | -$0.84 |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | $2.84 | $0.78 | $0.95 | $0.86 |
IONS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -13.99 |
| 2025Q3 | -17.09% | -22.99 |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | 12.72 |
IONS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -6.58% | ? |
| 2025Q4 | -1.24% | ? |
| 2025Q3 | -1.14% | 0.19% |
| 2025Q3 | -1.28% | ? |
| 2025Q2 | 2.18% | ? |
IONS
Price: $74.48
52 week price:
Earnings Per Share: -2.01 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Ebitda: 9.5 millionMarket Capitalization: 12.5 billion